Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 20, 2024
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
[ Tue, Feb 20th 2024
] - WOPRAI
Robert Burns Maintained (ADCT) at Strong Buy with Increased Target to $9 on, Feb 20th, 2024
Robert Burns of HC Wainwright & Co., Maintained "ADC Therapeutics SA" (ADCT) at Strong Buy with Increased Target from $3 to $9 on, Feb 20th, 2024.
Robert has made no other calls on ADCT in the last 4 months.
There are 2 other peers that have a rating on ADCT. Out of the 2 peers that are also analyzing ADCT, 1 agrees with Robert's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Boris Peaker of "TD Cowen" Downgraded from Buy to Hold on, Thursday, November 9th, 2023
This is the rating of the analyst that currently disagrees with Robert
- Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $6 on, Wednesday, November 8th, 2023
